Literature DB >> 16941198

Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis.

Pilar Peris1, Ana Monegal, M Angeles Martínez, Concepción Moll, Françesca Pons, Nuria Guañabens.   

Abstract

Idiopathic osteoporosis is a frequent cause of osteoporosis in young premenopausal women. However, there are no data about the treatment of these patients. The aim of this study was to analyse the evolution of bone mineral density (BMD) in premenopausal women with idiopathic osteoporosis treated with a conservative approach. Retrospective study of 16 premenopausal women with idiopathic osteoporosis (aged 35.7+/-7 years) with a mean follow-up period of 3 years (1-6 years). BMD measurements at the lumbar spine and femoral neck were obtained in all patients at baseline and yearly (patients had one or more fragility fractures and/or a Z score < -2 in the lumbar spine or femur). Secondary causes of osteoporosis were excluded in all patients. Patients were treated with calcium and vitamin D to achieve a calcium intake of up to 1,500 mg/day and were advised to increase physical activity. A significant increase in lumbar and femoral BMD was observed after 2 and 3 years of follow-up, respectively (1.9+/-1.9% mean increase in lumbar spine, p= 0.021, at 2 years) (5.6+/-4.5% mean increase in femur, p=0.04, at 3 years). The serum total alkaline phosphatase (TAP) values increased at 2 years (122+/-46 vs 140+/-36 U/l, p=0.054). In addition, a negative correlation between baseline TAP serum values and lumbar BMD evolution at 2 years was observed (r=-0.748, p=0.013). No patient developed new skeletal fractures during the follow-up period. In young premenopausal women with idiopathic osteoporosis the conservative treatment with supplements of calcium and vitamin D associated with an increase of physical activity is associated with an increase in BMD without evidence of further skeletal fractures after more than 3 years of follow-up.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16941198     DOI: 10.1007/s10067-006-0405-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  17 in total

1.  Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.

Authors:  J A Kanis; P Delmas; P Burckhardt; C Cooper; D Torgerson
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 2.  Bone mass measurement for premenopausal women.

Authors:  R Lindsay
Journal:  Osteoporos Int       Date:  1994       Impact factor: 4.507

3.  Weight-bearing activity during youth is a more important factor for peak bone mass than calcium intake.

Authors:  D C Welten; H C Kemper; G B Post; W Van Mechelen; J Twisk; P Lips; G J Teule
Journal:  J Bone Miner Res       Date:  1994-07       Impact factor: 6.741

4.  Walking and leisure-time activity and risk of hip fracture in postmenopausal women.

Authors:  Diane Feskanich; Walter Willett; Graham Colditz
Journal:  JAMA       Date:  2002-11-13       Impact factor: 56.272

5.  [Prevalence of osteoporosis assessed by densitometry in the Spanish female population].

Authors:  M Díaz Curiel; J J García; J L Carrasco; J Honorato; R Pérez Cano; A Rapado; C Alvarez Sanz
Journal:  Med Clin (Barc)       Date:  2001-01-27       Impact factor: 1.725

6.  Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial.

Authors:  I R Reid; R W Ames; M C Evans; G D Gamble; S J Sharpe
Journal:  Am J Med       Date:  1995-04       Impact factor: 4.965

7.  Vitamin D3 and calcium to prevent hip fractures in elderly women.

Authors:  M C Chapuy; M E Arlot; F Duboeuf; J Brun; B Crouzet; S Arnaud; P D Delmas; P J Meunier
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

8.  Calcium supplementation and bone mineral density in adolescent girls.

Authors:  T Lloyd; M B Andon; N Rollings; J K Martel; J R Landis; L M Demers; D F Eggli; K Kieselhorst; H E Kulin
Journal:  JAMA       Date:  1993-08-18       Impact factor: 56.272

9.  Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women.

Authors:  Pilar Peris; Núria Guañabens; Ma Jesús Martínez de Osaba; Ana Monegal; Luisa Alvarez; Francesca Pons; Inmaculada Ros; Dacia Cerdá; José Muñoz-Gómez
Journal:  Semin Arthritis Rheum       Date:  2002-08       Impact factor: 5.532

Review 10.  Official positions of the International Society for Clinical Densitometry.

Authors:  Edward S Leib; E Michael Lewiecki; Neil Binkley; Ronald C Hamdy
Journal:  J Clin Densitom       Date:  2004       Impact factor: 2.963

View more
  10 in total

Review 1.  Premenopausal bone health: osteoporosis in premenopausal women.

Authors:  Alice Abraham; Adi Cohen; Elizabeth Shane
Journal:  Clin Obstet Gynecol       Date:  2013-12       Impact factor: 2.190

Review 2.  Premenopausal Osteoporosis.

Authors:  Adi Cohen
Journal:  Endocrinol Metab Clin North Am       Date:  2016-11-24       Impact factor: 4.741

3.  Evaluation and management of the premenopausal woman with low BMD.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

4.  Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis.

Authors:  Adi Cohen; X Sherry Liu; Emily M Stein; Donald J McMahon; Halley F Rogers; Jeanette Lemaster; Robert R Recker; Joan M Lappe; X Edward Guo; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

5.  Effects of physical training on bone mineral density in fertile women with idiopathic osteoporosis.

Authors:  Ingrid Bergström; Jonas Brinck; Maria Sääf
Journal:  Clin Rheumatol       Date:  2008-04-29       Impact factor: 2.980

6.  Clinical characteristics and medication use among premenopausal women with osteoporosis and low BMD: the experience of an osteoporosis referral center.

Authors:  Adi Cohen; Jessica Fleischer; Matthew J Freeby; Donald J McMahon; Dinaz Irani; Elizabeth Shane
Journal:  J Womens Health (Larchmt)       Date:  2009 Jan-Feb       Impact factor: 2.681

Review 7.  Treatment of premenopausal women with low bone mineral density.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Curr Osteoporos Rep       Date:  2008-03       Impact factor: 5.096

8.  Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis.

Authors:  F Vescini; R Attanasio; A Balestrieri; F Bandeira; S Bonadonna; V Camozzi; S Cassibba; R Cesareo; I Chiodini; C Maria Francucci; L Gianotti; F Grimaldi; R Guglielmi; B Madeo; C Marcocci; A Palermo; A Scillitani; E Vignali; V Rochira; M Zini
Journal:  J Endocrinol Invest       Date:  2016-03-11       Impact factor: 4.256

Review 9.  Early-Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen.

Authors:  Alice Costantini; Riikka E Mäkitie; Markus A Hartmann; Nadja Fratzl-Zelman; M Carola Zillikens; Uwe Kornak; Kent Søe; Outi Mäkitie
Journal:  J Bone Miner Res       Date:  2022-09-11       Impact factor: 6.390

Review 10.  Early-Onset Osteoporosis.

Authors:  Outi Mäkitie; M Carola Zillikens
Journal:  Calcif Tissue Int       Date:  2021-07-08       Impact factor: 4.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.